Abstract
AbstractA collection of clinical data was conducted to assess the performance and tolerability of Cerviron®ovules in the treatment and management of various types of vaginitis in clinical practice. A total of 111 women aged between 20 and 70 years were included, 71 of whom were treated with Cerviron®ovules as monotherapy and 40 who used Cerviron®ovules as supportive treatment in conjunction with antibiotic therapy. The aim of our study was to assess the relief in vaginal symptoms and changes in the normal vaginal pH level after 3 months of treatment with Cerviron®medical device in real-life clinical practice settings. The results showed that Cerviron®ovules are well tolerated and effective as monotherapy and also as an adjuvant to antibiotic therapy. The study and its details are registered inwww.clinicaltrials.govunder IDNCT05652959.
Publisher
Cold Spring Harbor Laboratory
Reference22 articles.
1. The Role of Bacterial Vaginosis and Trichomonas in HIV Transmission Across The Female Genital Tract
2. Recent Advances in Presentation, Diagnosis and Treatment for Mixed Vaginitis;Front Cell Infect Microbiol,2021
3. A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of Metronidazole Vaginal Gel 1.3% in the Treatment of Bacterial Vaginosis
4. Improving the Diagnosis of Vulvovaginitis: Perspectives to Align Practice, Guidelines, and Awareness;Popul Health Manag,2020
5. Improving the Diagnosis of Vulvovaginitis: Perspectives to Align Practice, Guidelines, and Awareness;Popul Health Manag,2020